SAN DIEGO, September 13, 2018-- Prominex, Inc., a molecular diagnostic company focused on point-of-care infectious disease testing, today announces completion of its Series A-1 financing, raising $4 million from Casdin Capital LLC and its founding CEO. The Series A-1 financing will provide funding to advance the development of its infectious disease assays and commence an instrument development partnership with Invetech, a global leader in point-of-care instrument design and development.